FEBUDIM40

About

FEBUDIM40 contains Febuxostat 40mg, a xanthine oxidase inhibitor used for the long-term management of hyperuricemia in patients with gout. It works by selectively inhibiting xanthine oxidase, an enzyme responsible for the production of uric acid. By reducing the formation of uric acid, Febuxostat helps to lower serum uric acid levels, thereby preventing the formation of uric acid crystals in joints and tissues, which are the cause of gout flares.

This medication is particularly useful for patients who cannot tolerate allopurinol or for whom allopurinol is ineffective. It is important to note that FEBUDIM40 is not intended for the acute treatment of gout attacks but rather for their prevention. Treatment should be initiated at a low dose and gradually increased if necessary, with regular monitoring of serum uric acid levels to achieve the target range. Consistent use helps to reduce the frequency and severity of gout flares and prevent joint damage.

Uses

• Long-term management of hyperuricemia
• Prevention of gout flares
• Treatment of chronic gout
• Reduction of serum uric acid levels

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician. Do not stop treatment abruptly.

Benefits

• Effectively lowers serum uric acid
• Reduces frequency of gout flares
• Prevents joint damage from uric acid crystals
• Alternative for allopurinol-intolerant patients
• Improves quality of life for gout sufferers
• Convenient once-daily dosing

Side Effects

• Nausea
• Diarrhea
• Headache
• Dizziness
• Skin rash
• Liver function abnormalities
• Joint pain (gout flares, especially initially)
• Chest pain
• Palpitations
• Fatigue
• Edema
• Hypersensitivity reactions (rare)

Safety Measures

• Alcohol - Alcohol can increase uric acid levels and trigger gout flares. Limit or avoid alcohol consumption during treatment.
• Pregnancy - Not recommended during pregnancy due to limited safety data; use only if potential benefits outweigh risks.
• Breastfeeding - It is unknown if Febuxostat is excreted in breast milk. Avoid use during breastfeeding or consult your doctor.
• Liver - Use with caution in patients with mild to moderate liver impairment; contraindicated in severe liver disease. Regular monitoring of liver function is essential.
• Kidney - Use with caution in patients with severe kidney impairment; dosage adjustment may be necessary.
• Lung - No specific contraindications or precautions for lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.